Detalhe da pesquisa
1.
Phase 1 study of everolimus and low-dose oral cyclophosphamide in patients with metastatic renal cell carcinoma.
Cancer Immunol Immunother
; 68(2): 319-329, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30413837
2.
Metronomic cyclophosphamide attenuates mTOR-mediated expansion of regulatory T cells, but does not impact clinical outcome in patients with metastatic renal cell cancer treated with everolimus.
Cancer Immunol Immunother
; 68(5): 787-798, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30756132
3.
The effect of everolimus and low-dose cyclophosphamide on immune cell subsets in patients with metastatic renal cell carcinoma: results from a phase I clinical trial.
Cancer Immunol Immunother
; 68(3): 503-515, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-30652208
4.
Sensing of latent EBV infection through exosomal transfer of 5'pppRNA.
Proc Natl Acad Sci U S A
; 113(5): E587-96, 2016 Feb 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-26768848
5.
Highly specific and potently activating Vγ9Vδ2-T cell specific nanobodies for diagnostic and therapeutic applications.
Clin Immunol
; 169: 128-138, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27373969
6.
Intradermal delivery of TLR agonists in a human explant skin model: preferential activation of migratory dendritic cells by polyribosinic-polyribocytidylic acid and peptidoglycans.
J Immunol
; 190(7): 3338-45, 2013 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23467931
7.
T cell profiling reveals high CD4+CTLA-4 + T cell frequency as dominant predictor for survival after prostate GVAX/ipilimumab treatment.
Cancer Immunol Immunother
; 62(2): 245-56, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22878899
8.
Characterization of four conventional dendritic cell subsets in human skin-draining lymph nodes in relation to T-cell activation.
Blood
; 118(9): 2502-10, 2011 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21750314
9.
A Reconstructed Human Melanoma-in-Skin Model to Study Immune Modulatory and Angiogenic Mechanisms Facilitating Initial Melanoma Growth and Invasion.
Cancers (Basel)
; 15(10)2023 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37345186
10.
Longitudinal immune monitoring of patients with resectable esophageal adenocarcinoma treated with Neoadjuvant PD-L1 checkpoint inhibition.
Oncoimmunology
; 12(1): 2233403, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37470057
11.
Local delivery of low-dose anti-CTLA-4 to the melanoma lymphatic basin leads to systemic Treg reduction and effector T cell activation.
Sci Immunol
; 7(73): eabn8097, 2022 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35857579
12.
Loss of FLCN-FNIP1/2 induces a non-canonical interferon response in human renal tubular epithelial cells.
Elife
; 102021 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33459596
13.
Adenocarcinoma of the Uterine Cervix Shows Impaired Recruitment of cDC1 and CD8+ T Cells and Elevated ß-Catenin Activation Compared with Squamous Cell Carcinoma.
Clin Cancer Res
; 26(14): 3791-3802, 2020 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32220890
14.
Constitutively active GSK3ß as a means to bolster dendritic cell functionality in the face of tumour-mediated immune suppression.
Oncoimmunology
; 8(10): e1631119, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31646076
15.
A CD34(+) human cell line model of myeloid dendritic cell differentiation: evidence for a CD14(+)CD11b(+) Langerhans cell precursor.
J Leukoc Biol
; 80(6): 1337-44, 2006 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-16959899
16.
High Levels of EBV-Encoded RNA 1 (EBER1) Trigger Interferon and Inflammation-Related Genes in Keratinocytes Expressing HPV16 E6/E7.
PLoS One
; 12(1): e0169290, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28056059
17.
A bispecific nanobody approach to leverage the potent and widely applicable tumor cytolytic capacity of Vγ9Vδ2-T cells.
Oncoimmunology
; 7(1): e1375641, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29296532
18.
Blocking Tumor-Educated MSC Paracrine Activity Halts Osteosarcoma Progression.
Clin Cancer Res
; 23(14): 3721-3733, 2017 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28053020
19.
Myeloid derived suppressor and dendritic cell subsets are related to clinical outcome in prostate cancer patients treated with prostate GVAX and ipilimumab.
J Immunother Cancer
; 2: 31, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-26196012
20.
Induction of dendritic cell maturation in the skin microenvironment by soluble factors derived from colon carcinoma.
Hum Vaccin Immunother
; 10(6): 1622-32, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24732313